Literature DB >> 20144334

Intermediary variables and algorithm parameters for an electronic algorithm for intravenous insulin infusion.

Susan S Braithwaite1, Hemant Godara, Julie Song, Bruce A Cairns, Samuel W Jones, Guillermo E Umpierrez.   

Abstract

BACKGROUND: Algorithms for intravenous insulin infusion may assign the infusion rate (IR) by a two-step process. First, the previous insulin infusion rate (IR(previous)) and the rate of change of blood glucose (BG) from the previous iteration of the algorithm are used to estimate the maintenance rate (MR) of insulin infusion. Second, the insulin IR for the next iteration (IR(next)) is assigned to be commensurate with the MR and the distance of the current blood glucose (BG(current)) from target. With use of a specific set of algorithm parameter values, a family of iso-MR curves is created, each giving IR as a function of MR and BG.
METHOD: To test the feasibility of estimating MR from the IR(previous) and the previous rate of change of BG, historical hyperglycemic data points were used to compute the "maintenance rate cross step next estimate" (MR(csne)). Historical cases had been treated with intravenous insulin infusion using a tabular protocol that estimated MR according to column-change rules. The mean IR on historical stable intervals (MR(true)), an estimate of the biologic value of MR, was compared to MR(csne) during the hyperglycemic iteration immediately preceding the stable interval. Hypothetically calculated MR(csne)-dependent IR(next) was compared to IR(next) assigned historically. An expanded theory of an algorithm is developed mathematically. Practical recommendations for computerization are proposed.
RESULTS: The MR(true) determined on each of 30 stable intervals and the MR(csne) during the immediately preceding hyperglycemic iteration differed, having medians with interquartile ranges 2.7 (1.2-3.7) and 3.2 (1.5-4.6) units/h, respectively. However, these estimates of MR were strongly correlated (R(2) = 0.88). During hyperglycemia at 941 time points the IR(next) assigned historically and the hypothetically calculated MR(csne)-dependent IR(next) differed, having medians with interquartile ranges 4.0 (3.0-6.0) and 4.6 (3.0-6.8) units/h, respectively, but these paired values again were correlated (R(2) = 0.87). This article describes a programmable algorithm for intravenous insulin infusion. The fundamental equation of the algorithm gives the relationship among IR; the biologic parameter MR; and two variables expressing an instantaneous rate of change of BG, one of which must be zero at any given point in time and the other positive, negative, or zero, namely the rate of change of BG from below target (rate of ascent) and the rate of change of BG from above target (rate of descent). In addition to user-definable parameters, three special algorithm parameters discoverable in nature are described: the maximum rate of the spontaneous ascent of blood glucose during nonhypoglycemia, the glucose per daily dose of insulin exogenously mediated, and the MR at given patient time points. User-assignable parameters will facilitate adaptation to different patient populations.
CONCLUSIONS: An algorithm is described that estimates MR prior to the attainment of euglycemia and computes MR-dependent values for IR(next). Design features address glycemic variability, promote safety with respect to hypoglycemia, and define a method for specifying glycemic targets that are allowed to differ according to patient condition. Copyright 2009 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20144334      PMCID: PMC2769966          DOI: 10.1177/193229680900300432

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  51 in total

1.  Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach.

Authors:  A Natali; A Gastaldelli; S Camastra; A M Sironi; E Toschi; A Masoni; E Ferrannini; A Mari
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-05       Impact factor: 4.310

2.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

3.  Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery.

Authors:  Lawrence J Markovitz; Robert J Wiechmann; Natalie Harris; Vicky Hayden; Joseph Cooper; Gilbert Johnson; Randy Harelstad; Lu Calkins; Susan S Braithwaite
Journal:  Endocr Pract       Date:  2002 Jan-Feb       Impact factor: 3.443

4.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.

Authors:  Anthony P Furnary; Guangqiang Gao; Gary L Grunkemeier; YingXing Wu; Kathryn J Zerr; Stephen O Bookin; H Storm Floten; Albert Starr
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

5.  Comparison of point-of-care and laboratory glucose analysis in critically ill patients.

Authors:  Teresita Lacara; Caroline Domagtoy; Donna Lickliter; Kathy Quattrocchi; Lydia Snipes; Joánne Kuszaj; MaryClare Prasnikar
Journal:  Am J Crit Care       Date:  2007-07       Impact factor: 2.228

6.  Eliminating the diabetic disadvantage: the Portland Diabetic Project.

Authors:  Anthony P Furnary; YingXing Wu
Journal:  Semin Thorac Cardiovasc Surg       Date:  2006

Review 7.  Hypoglycemia in diabetes.

Authors:  Philip E Cryer; Stephen N Davis; Harry Shamoon
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

8.  Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit.

Authors:  Rattan Juneja; Corbin Roudebush; Nilay Kumar; Angela Macy; Adam Golas; Donna Wall; Cheryl Wolverton; Deborah Nelson; Joni Carroll; Samuel J Flanders
Journal:  Diabetes Technol Ther       Date:  2007-06       Impact factor: 6.118

9.  Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profiles.

Authors:  Sunder Mudaliar; Pharis Mohideen; Reena Deutsch; Theodore P Ciaraldi; Debra Armstrong; Bo Kim; Xue Sha; Robert R Henry
Journal:  Diabetes Care       Date:  2002-09       Impact factor: 19.112

10.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Authors:  Etie S Moghissi; Mary T Korytkowski; Monica DiNardo; Daniel Einhorn; Richard Hellman; Irl B Hirsch; Silvio E Inzucchi; Faramarz Ismail-Beigi; M Sue Kirkman; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2009-05-08       Impact factor: 19.112

View more
  1 in total

1.  An evaluation of "I, Pancreas" algorithm performance in silico.

Authors:  Malgorzata E Wilinska; Marianna Nodale
Journal:  J Diabetes Sci Technol       Date:  2009-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.